AAAAAA

   
Results: 1-6 |
Results: 6
A PHASE-I TRIAL OF STANDARD AND CYCLOPHOSPHAMIDE DOSE-ESCALATED CHOP WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN ELDERLY PATIENTS WITH NON-HODGKINS-LYMPHOMA
Authors: MEYER RM GYGER M LANGLEY R LESPERANCE B CAPLAN SN
Citation: Rm. Meyer et al., A PHASE-I TRIAL OF STANDARD AND CYCLOPHOSPHAMIDE DOSE-ESCALATED CHOP WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN ELDERLY PATIENTS WITH NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 30(5-6), 1998, pp. 591-600
GASTRIC LYMPHOMAS - A CLINICOPATHOLOGICAL STUDY OF 123 CASES
Authors: TRUDEL M LESPERANCE B LAMARRE L DESCHENES J VUONG T
Citation: M. Trudel et al., GASTRIC LYMPHOMAS - A CLINICOPATHOLOGICAL STUDY OF 123 CASES, Modern pathology, 11(1), 1998, pp. 141-141
PREVENTION OF VENOUS THROMBOEMBOLISM AFTER KNEE ARTHROPLASTY - A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING ENOXAPARIN WITH WARFARIN
Authors: LECLERC JR GEERTS WH DESJARDINS L LAFLAMME GH LESPERANCE B DEMERS C KASSIS J CRUICKSHANK M WHITMAN L DELORME F
Citation: Jr. Leclerc et al., PREVENTION OF VENOUS THROMBOEMBOLISM AFTER KNEE ARTHROPLASTY - A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING ENOXAPARIN WITH WARFARIN, Annals of internal medicine, 124(7), 1996, pp. 619
PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER KNEE ARTHROPLASTY - A RANDOMIZED, DOUBLE-BLIND TRIAL, COMPARING A LOW-MOLECULAR-WEIGHT HEPARIN FRAGMENT (ENOXAPARIN) TO WARFARIN
Authors: LECLERC JR GEERTS WH DESJARDINS L LESPERANCE B CRUICKSHANK M DEMERS C JOBIN F KASSIS J WHITMAN L LAFLAMME G DELORME F BOURGOUIN J
Citation: Jr. Leclerc et al., PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER KNEE ARTHROPLASTY - A RANDOMIZED, DOUBLE-BLIND TRIAL, COMPARING A LOW-MOLECULAR-WEIGHT HEPARIN FRAGMENT (ENOXAPARIN) TO WARFARIN, Thrombosis and haemostasis, 73(6), 1995, pp. 1103-1103
A PHASE-II, OPEN-LABEL STUDY TO EVALUATE 2 DIFFERENT SCHEDULES FOR INTEGRATING FILGRASTIM (RECOMBINANT-METHIONYL HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) AS ADJUVANT THERAPY IN THE TREATMENT OF PATIENTS WITH HODGKINS LYMPHOMA RECEIVING MOPP ABV HYBRID CHEMOTHERAPY/
Authors: CANTIN G LESPERANCE B YELLE L BELANGER D CANTIN G BERGERON M DESJARDINS L OUELLET P DUFRESNE J BEAUREGARD P LEPINE M LACROIX L COUTURE F GYGER M
Citation: G. Cantin et al., A PHASE-II, OPEN-LABEL STUDY TO EVALUATE 2 DIFFERENT SCHEDULES FOR INTEGRATING FILGRASTIM (RECOMBINANT-METHIONYL HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) AS ADJUVANT THERAPY IN THE TREATMENT OF PATIENTS WITH HODGKINS LYMPHOMA RECEIVING MOPP ABV HYBRID CHEMOTHERAPY/, Blood, 86(10), 1995, pp. 197-197
PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER KNEE ARTHROPLASTY - A RANDOMIZED, DOUBLE-BLIND TRIAL, COMPARING A LOW-MOLECULAR-WEIGHT HEPARIN FRAGMENT (ENOXAPARIN) TO WARFARIN
Authors: LECLERC JR GEERTS WH DESJARDINS L LESPERANCE B CRUICKSHANK M DEMERS C JOBIN F KASSIS J WHITMAN L LAFLAMME G DELORME F BOURGOUIN J
Citation: Jr. Leclerc et al., PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER KNEE ARTHROPLASTY - A RANDOMIZED, DOUBLE-BLIND TRIAL, COMPARING A LOW-MOLECULAR-WEIGHT HEPARIN FRAGMENT (ENOXAPARIN) TO WARFARIN, Blood, 84(10), 1994, pp. 10000246-10000246
Risultati: 1-6 |